RB1 and breast carcinoma: Furthermore, it has been reported that LEP in breast cancer models, via JAK2/STAT3 pathway, promotes cell cycle progression by increasing the expression of cdk2 and cyclin D1 levels, thus inducing hyperphosphorylation and subsequent inactivation of the cell cycle inhibitor Rb [54].